Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. Writing in The Lancet, PATH's Dykki Settle, Henry Mwanyika, and co-authors identify three investment areas that could transform primary health care.
    Published: November 2023
  2. Africa Centres for Disease Control and Prevention, the Clinton Health Access Initiative, and PATH examined the current and planned vaccine manufacturing capacity in Africa to better understand how to develop a sustainable vaccine manufacturing ecosystem.
    Published: October 2023
  3. An analysis of the RTS,S malaria vaccine in Africa shows it decreased toddler deaths by 13 percent. PATH’s John Bawa speaks with Science about these remarkable results.
    Published: October 2023
  4. From health data exchanges to a telemedicine task force, PATH’s Varun Kaul and co-author Anirban Sarma break down eight approaches that the G20 could take to strengthen digital health across its member states.
    Published: October 2023

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

946 Item s
946 Item s
    Date
    From
    To
  1. The CEPI-backed Research Preparedness Program in East and Central Africa aims to bolster regional clinical trial capacity and disease outbreak readiness.
    Published: March 2025
    Press Release
  2. Published: March 2025
    Announcement
  3. Results from a Phase 3 clinical study of Innovax’s WHO prequalified vaccine can help expand access globally and give countries another option for affordable, sustainable HPV vaccine.
    Published: March 2025
    Announcement
  4. The milestone marks the first-ever prequalification of an RSV vaccine and paves the way for improving respiratory disease prevention for infants around the world.
    Published: March 2025
    Statement
  5. The new Center enhances collaboration between PATH's technical and advocacy experts, boosting our ability to expand access to lifesaving health care through policy.
    Published: March 2025
    Press Release